Transgenic AD model mice, effects of potential anti-AD treatments on inflammation and pathology
- 1 April 2005
- journal article
- research article
- Published by Elsevier in Brain Research Reviews
- Vol. 48 (2), 370-378
- https://doi.org/10.1016/j.brainresrev.2004.12.026
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Estrogen treatment improves spatial learning in APP + PS1 mice but does not affect beta amyloid accumulation and plaque formationExperimental Neurology, 2004
- Neuroinflammatory perspectives on the two faces of Alzheimer?s diseaseJournal of Neural Transmission, 2004
- Toward Alzheimer Therapies Based on Genetic KnowledgeAnnual Review of Medicine, 2004
- Estrogen and Raloxifene Activities on Amyloid-β-Induced Inflammatory ReactionMicrovascular Research, 2001
- The amyloid precursor protein of Alzheimer’s disease and the Aβ peptideNeuropathology and Applied Neurobiology, 1999
- MUTANT GENES IN FAMILIAL ALZHEIMER'S DISEASE AND TRANSGENIC MODELSAnnual Review of Neuroscience, 1998
- Familial Alzheimer's Disease–Linked Presenilin 1 Variants Elevate Aβ1–42/1–40 Ratio In Vitro and In VivoNeuron, 1996
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991
- Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reportedPublished by American Medical Association (AMA) ,1989
- Alzheimer's Disease: A Disorder of Cortical Cholinergic InnervationScience, 1983